Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: Rationale and design

Vorapaxar in the Secondary Prevention of Atherothrombotic Events

(2012) David A. Morrow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Heart Disease and Stroke Statistics—2012 Update

(2011) et al.   CIRCULATION

Rationale and design of a randomized, double-blind trial comparing the effects of a 3-month clopidogrel-aspirin regimen versus aspirin alone for the treatment of high-risk patients with acute nondisabling cerebrovascular event

(2010) Yongjun Wang et al.   AMERICAN HEART JOURNAL

Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Definition and Evaluation of Transient Ischemic Attack

(2009) J. Donald Easton et al.   STROKE

Early and Late Benefits of Prasugrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

(2008) Elliott M. Antman et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke

(2008) Ralph L. Sacco et al.   NEW ENGLAND JOURNAL OF MEDICINE

Recurrent Events in Transient Ischemic Attack and Minor Stroke

(2008) Shelagh B. Coutts et al.   STROKE